THE SURVIVAL RATE OF LC IS 15.5%.
THAT’S UNACCEPTABLE. WE’RE
HERE TO CHANGE THAT.

 

Archive for May, 2007

Multis, C & E, Folate OK for Lungs

vits.jpgMultivitamins, vitamins C and E, and folate neither decreased nor increased the risk of lung cancer, according to findings presented at the American Thoracic Society International Conference (May, 2007).
The 77,738 men and women (aged 50 to 76) enrolled in the Vitamins And Lifestyle (VITAL) study, filled out an extensive questionnaire on their vitamin intake over the previous 10 years, including the quantities of each supplement taken. The researchers then investigated how many of these men and women had lung cancer (using a government cancer registry); and found 393 cases of lung cancer. In adjusting for such risk factors as smoking, age, sex, cancer history, other lung disease and history of lung cancer, researchers found no statistically significant relationships between different types of supplements and lung cancer.

 

No Comments | Trackback | Permalink

 

Antisoma flags Phase III lung cancer trial

antisoma.jpgShares in biotech minnow Antisoma rose after it revealed that partner Novartis will begin enrolling patients for Phase III trials of A1404, its promising lung cancer candidate, early next year.

 

No Comments | Trackback | Permalink

 

Cardiff helps China beat cancer

cardiff.jpgCardiff University is to help China tackle growing problems with cancer after agreeing two new joint research projects with leading Chinese universities.

The first agreement is a collaboration on lung cancer with the Health Science Centre at Peking University, the leading medical research and teaching institution in China. Although smoking is now declining in China, the country is likely to have a significant lung cancer problem for years to come and the Chinese Government is anxious to tackle the problem.

 

No Comments | Trackback | Permalink

 

TX: Statewide smoking ban snuffed

KCRG_news_no-smoking-ban.jpgProponents of a statewide smoking ban in restaurants, bars and work places acknowledged defeat on the issue Thursday, but vowed to pursue it again in the 2009 session.

 

No Comments | Trackback | Permalink

 

Oral and IV Hycamtin® Equally Effective for Small Cell Lung Cancer

hycamtin.jpgResearchers involved in an International Study have confirmed that the oral form of Hycamtin is as effective as the IV form for the second line palliative treatment of small cell lung cancer (SCLC). The details of this randomized trial appeared in the May 20, 2007 issue of the Journal of Clinical Oncology.

 

No Comments | Trackback | Permalink

 

Qantas in cancer payout

qantas.jpgEmbattled air giant Qantas could potentially be exposed to tens of millions of dollars in compensation after a dying aircraft maintenance worker was awarded almost $1 million for lung cancer he contracted after working for the airline.

 

No Comments | Trackback | Permalink

 

‘Mum’s cancer battle is my running inspiration’

walk.jpgWendy, who lost her mother to lung cancer last year, was inspired to run because it helps her remember the tough battle faced by her mum.

She told the Belfast Telegraph: “The reason that I take part in the race for life is two-fold. Firstly, I currently work as a postdoctoral research fellow in the Centre for Cancer Research and Cell Biology in Queen’s University Belfast.

 

No Comments | Trackback | Permalink

 

New Erbitux study to steal cancer spotlight

vials.jpgBristol is also expected to release study results involving Sprycel, its treatment for chronic myeloid leukemia, and three additional experimental drugs: ixabepilone for breast cancer; ipilimumab for melanoma and prostate cancer; and vinflunine for cancer of the lung and breast

 

No Comments | Trackback | Permalink

 

Geauga County man conquers Mt. Everest

everst.jpgBrian Oestrike of Bainbridge Township summitted Mt. Everest Wednesday morning, around 2 a.m. Eastern Standard Time. Oestrike, 27, climbed Mt. Everest as a tribute to his mother, Jackie, who died of lung cancer last year even though she never smoked.

 

No Comments | Trackback | Permalink

 

Poniard Pharmaceuticals Announces Clinical Data from Picoplatin Phase 2 Small Cell Lung Cancer Trial To Be Presented at American Society of Clinical Oncology Annual Meeting

poniard.jpgPoniard Pharmaceuticals, Inc., a biopharmaceutical company focused on oncology, today announced that data from a Phase 2 trial of picoplatin, the Company’s lead product candidate, in patients with small cell lung cancer (SCLC) will be presented in a poster session at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) at McCormick Place in Chicago.

 

No Comments | Trackback | Permalink